Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ELANFRA:25E 92 EV-to-EBIT is 8.03 as of Aug. 31, 2026, which is 59% below its 10-year median of 19.48. GuruFocus rates FRA:25E with a GF Score™ of 92/100 and a GF Value™ of €4.86. The stock has 3 warning signs investors should review. Among 477 Healthcare Providers & Services companies, ELAN ranks better than 81.13% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, ELAN's Enterprise Value is €212.1 Mil.
ELAN's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was €26.4 Mil. Therefore, ELAN's EV-to-EBIT for today is 8.03.
The historical rank and industry rank for ELAN's EV-to-EBIT or its related term are showing as below:
FRA:25E'
s EV-to-EBIT Range Over the Past 10 Years
Min: 8.15 Med: 19.48 Max: 48.49
Current: 8.21
During the past 13 years, the highest EV-to-EBIT of ELAN was 48.49. The lowest was 8.15. And the median was 19.48.
FRA:25E's EV-to-EBIT is ranked better than 81.13% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 15.73
vs FRA:25E: 8.21
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
ELAN's Enterprise Value for the quarter that ended in Jun. 2026 was €198.6 Mil.
ELAN's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €26.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ELAN EV-to-EBIT Related Terms
ELAN EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for ELAN's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, ELAN's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ELAN EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ELAN's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where ELAN's EV-to-EBIT falls into.
ELAN's current Enterprise Value is €212.1 Mil.
ELAN's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €26.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ELAN (FRA:25E) has a EV-to-EBIT of 8.03 as of Aug. 31, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on ELAN and its competitors. This is 59% below median its historical median of 19.48. Over the past decade, ELAN's EV-to-EBIT has ranged from 8.15 to 48.49. According to the industry distribution chart, ELAN ranks #90 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 18.9%.
Is ELAN's EV-to-EBIT too high?
ELAN's current EV-to-EBIT of 8.03 is 59% below median its 10-year median of 19.48. Over the past 10 years, this metric has ranged from a low of 8.15 to a high of 48.49. The Healthcare Providers & Services industry median EV-to-EBIT is 15.73. ELAN's value of 8.03 is 49% below this industry median. Based on the distribution chart, ELAN ranks #90 out of 477 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, ELAN has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does ELAN's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, ELAN ranks #90 out of 477 companies for EV-to-EBIT. This places ELAN in the top 19% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 15.73. ELAN's value of 8.03 is 49% below this benchmark. Historically, ELAN's own EV-to-EBIT has ranged from 8.15 to 48.49 over the past decade. While the company's 10-year median is 19.48 vs. the industry median of 15.73, ELAN has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.73, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ELAN's current EV-to-EBIT of 8.03 is 49% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on ELAN and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ELAN's current EV-to-EBIT is 8.03, which is 59% below median its own 10-year median of 19.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ELAN stock overvalued right now?
ELAN (FRA:25E) has a current EV-to-EBIT of 8.03. The stock's GF Value™ is €4.86, compared to a current price of €3.84 — trading 21% below its estimated fair value. The current EV-to-EBIT is 8.03, which is 59% below median its 10-year median of 19.48 and 49% below the Healthcare Providers & Services industry median of 15.73. ELAN's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For ELAN (FRA:25E), the current EV-to-EBIT is 8.03 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ELAN (FRA:25E) Overvalued in 2026?
Based on GuruFocus' analysis, ELAN stock appears to be undervalued.
The current stock price of €3.84 is trading 21% below its estimated GF Value™ of €4.86.
Key valuation signals for FRA:25E:
EV-to-EBIT: 8.03 (59% below median its 10-year median of 19.48)
GF Value™: €4.86 vs. price of €3.84 (21% below fair value)
Industry Position: 49% below the Healthcare Providers & Services median (#90 of 477)
No single metric tells the full story. See the FRA:25E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ELAN Corp operates in the medical industry. The company provides the CS (Care Support) Set service, which combines the rental of clothing and towels, laundry services, and the provision of daily living goods. The service is offered to individuals in hospitals and nursing care facilities, including nursing homes and other care facilities. The CS Set allows users to access clothing, towels, and daily necessities through a combined rental and supply service.
92GF Score
Get the complete analysis for FRA:25E
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:25E has been successfully added to your 
